FIRST CLINICAL EXPERIENCE WITH FRACTIONATED INTRACAVITARY RADIOIMMUNOTHERAPY USING [177LU]LU-6A10-FAB FRAGMENTS IN PATIENTS WITH GLIOBLASTOMA: A PILOT STUDY

First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study

Abstract Background Following resection and standard adjuvant radio- and chemotherapy, approved maintenance therapies for glioblastoma are lacking.Intracavitary radioimmunotherapy (iRIT) with 177Lu-labeled 6A10-Fab fragments targeting tumor-associated carbonic anhydrase XII and injected into the resection cavity offers a novel and promising strateg

read more


Western lifestyle as a driver of dysbiosis in colorectal cancer

Landmark discoveries in pulley roller the gut microbiome field have paved the way for new research aimed at illuminating the influence of microbiota in colorectal cancer.A major challenge is to account for the effect of inherently variable environmental factors on the host and the gut microbiome, while concurrently determining their contribution to

read more